Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 60505-4895

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 60505-4895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister-plain-2.jpg (Blister Plain 2)

Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol 0.15 mg/0.02 mg and 0.01 mg, tablet kit packaging label. The label shows a 28-day dosing schedule with circles representing tablets for each day of the week and week, color-coded as white, yellow, and light green tablets. It includes storage instructions, manufacturing details by Naari Pharma Private Limited in India, and labeling by Apotex Corp.*

FDA Label Image

Blister-plain-final.jpg (Blister Plain Final)

Desogestrel and Ethinyl Estradiol Tablets kit by Apotex Corp., labeled NDC 60505-4895, featuring a 28-day blister pack with white, yellow, and light green tablets organized by week and day. The packaging includes dosage details, storage instructions, and manufacturer information.*

FDA Label Image

Blister-with Palm-2.jpg (Blister With Palm 2)

Label for desogestrel and ethinyl estradiol tablets, USP, with dosages 0.15 mg/0.02 mg and 0.01 mg, presented as a four-week daily dose kit. The label is from Apotex Corp., showing a calendar-style arrangement with circles for each day of the week over four weeks. It includes storage instructions (20° to 25°C) and manufacturer information (Naari Pharma Private Limited, made in India). The label is marked Rx only and includes a barcode.*

FDA Label Image

Blister-with Palm-final.jpg (Blister With Palm Final)

Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and 0.01 mg oral contraceptive tablet blister pack kit. The white rectangular pack is labeled for a 4-week supply with daily pill circles arranged in rows by week and day, including instructions to place a correct day label. Manufactured by Naari Pharma Private Limited and labeled by Apotex Corp.*

FDA Label Image

Carton-apotex-final.jpg (Carton Apotex Final)

Packaging label for desogestrel and ethinyl estradiol and ethinyl estradiol tablets kit by Apotex Corp. The label shows the product contains three blister cards with 28 tablets each, with strengths of 0.15 mg, 0.02 mg, and 0.01 mg respectively. The label includes dosage instructions, manufacturer details, barcodes, and regulatory text with the NDC 60505-4895-2.*

FDA Label Image

Description (Description)

Chemical structures of the active ingredients desogestrel and ethinyl estradiol. The desogestrel structure includes carbon, hydrogen, and oxygen atoms, represented with molecular formula C22H30O. The ethinyl estradiol structure shows a similar complex steroid framework with molecular formula C20H24O2.*

FDA Label Image

Figure 1.jpg (Figure 1)

A bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) categorized by smoking status and contraceptive use: ever-users (smokers and non-smokers) and controls (smokers and non-smokers). Mortality rate increases with age, notably high for ever-users who are smokers in older age groups.*

FDA Label Image

Figure 2.jpg (Figure 2)

A forest plot chart comparing the effect estimates (OR, RR, HR) for studies on combined oral contraceptive (COC) use: Ever COC versus Never COC use, and Current COC use versus Never use. The graph displays effect estimates with confidence intervals for each study along the x-axis labeled 'Effect Estimate.' Studies include NICHD Women's Care, French E3N, Shanghai Women's Health, Nurses' Health, Oxford Family Planning and Danish Sex Hormone Register.*

FDA Label Image

Table 1.jpg (Table 1)

Pharmacokinetic data tables for Etonogestrel and Ethinyl Estradiol, showing pharmacokinetic parameters such as dose, measured peak concentration (Cmax), time of peak concentration (Tmax), elimination half-life (t1/2), area under the concentration-time curve (AUC0-24), and apparent clearance (CL/F). The tables present values on different days with associated standard deviations in parentheses.*

FDA Label Image

Table2-final.jpg (Table2 Final)

A data table showing the annual number of birth-related or method-related deaths associated with fertility control methods per 100,000 non-sterile women, categorized by age groups 15 to 19, 20 to 24, 25 to 29, 30 to 34, 35 to 39, and 40 to 44. Methods include no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with notes indicating which deaths are birth related versus method related.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.